MedTrace Logo

HighLife™ Transcatheter Mitral Valve Replacement System Study

NCT02974881 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2024-10-03

No results posted yet for this study

Summary

Multicenter feasibility study of the HighLife™ TMVR system.

Conditions

  • Mitral Valve Regurgitation
  • Mitral Valve Insufficiency

Interventions

DEVICE

Transcatheter Mitral Valve Replacement

Minimally invasive transcatheter mitral valve implantation using the HighLife™ TMVR system

Sponsors & Collaborators

  • MedPass International

    collaborator INDUSTRY

  • ICON plc

    collaborator INDUSTRY

  • HighLife SAS

    lead INDUSTRY

Principal Investigators

  • Jean-Philippe Collet, MD · Groupe Hospitalier Pitié-Salpétrière Institut de Cardiologie

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-20
Primary Completion
2018-11-18
Completion
2024-01-16

Countries

  • France
  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02974881 on ClinicalTrials.gov